Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Whole-brain computer modelling reveals the effects of LSD on the human brain

A new method to model neuroimaging data could help to predict potential treatment outcomes for patients with mental health disorders. The study by researchers from Pompeu Fabra University, Spain, and the University of Oxford looked specifically at people with mental disorders attributable to diseases of the nervous system such as depression and addiction. The team involved used neuroimaging data of healthy participants who had been given LSD (lysergic acid diethylamide) and placebo treatments to prove the concept of the new computer model.

Find out more (Department of Psychiatry website)

Similar stories

The women founders contributing to Oxford’s spinout success

More spinout companies are created by the University of Oxford than any other UK University and an increasing number of their founders and senior leaders are women.

NICE recommends digital mental health technologies from Oxford

Two digital tools were recommended for use in the NHS to help children and young people with symptoms of anxiety or low mood.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Significant scale-up investment for three Oxford spinouts

Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.

Oxford Innovation Society celebrates pioneering biomedical research and innovation

Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.